Investing
Telehealth company Caregility, hybrid cancer care company Daymark Health and virtual care company AmplifyMD also garnered funding.
The company will use the funds to expand Dreem Health, scale nationwide and advance its FDA-cleared sleep apnea technology.
The Series D funding brings the company’s total raise to $275 million and its valuation to more than $1 billion.
The company anticipates doubling its revenue this year reaching $1 billion in sales.
The company stated Capital Rx will still operate as its pharmacy benefits manager brand under Judi Health.
The funds will be used to expand its customer base and invest in AI innovation.
T.Rx Capital aims to help companies build scalable platforms to reshape disease treatment.
The company will use the funds to expand nationally, enhance its technology platform and advance clinical innovation.
The funds will be used to expand its direct-to-consumer services and grow partnerships with payers and health systems.
The round follows a $200 million seed raise earlier this year.